L38 AF Global
- 0.095
- 0.0000.00%
AF Global News
AF Global (SGX:L38) Shareholders Have Endured a 8.8% Loss From Investing in the Stock Five Years Ago
AF Global Limited Unveils Scrip Dividend Option
AF Global Full Year 2023 Earnings: EPS: S$0.003 (Vs S$0.001 Loss in FY 2022)
Here's What To Make Of AF Global's (SGX:L38) Decelerating Rates Of Return
What AF Global Limited's (SGX:L38) 32% Share Price Gain Is Not Telling You
Despite an already strong run, AF Global Limited (SGX:L38) shares have been powering on, with a gain of 32% in the last thirty days. Looking further back, the 18% rise over the last twelve months i
Singapore Shares Rebound; Thomson Medical Slips 3%
Singapore's Straits Times Index ended in the green on Thursday, erasing losses from the previous session, following overnight gains in global markets as investors await key US inflation data due later
AF Global to Dispose of Certain Assets in Thailand for THB1.60 Billion; Shares Zoom 13%
AF Global (SGX:L38), via its subsidiaries, has agreed to dispose of RP Hotels (Thailand) as well as certain assets of the latter for an aggregate consideration of 1.60 billion baht to subsidiaries of
AF Global Halts Trade Pending Announcement
AF Global (SGX:L38) requested for a trading halt with the Singapore Exchange on Wednesday afternoon, pending the release of an announcement. The trading halt is effective immediately, according to a W
AF Global (SGX:L38) Investors Are Sitting on a Loss of 33% If They Invested Five Years Ago
AF Global's Sale of Equity Interest in Subsidiary Falls Through
AF Global's (SGX:L38) proposed sale of its 55% equity interest in Xuzhou Yinjian LumChang Real Estate Development has fallen through. The sale collapsed due to the purchasers' failure to complete the
Returns On Capital At AF Global (SGX:L38) Have Hit The Brakes
AF Global (SGX:L38) Shareholders Have Endured a 37% Loss From Investing in the Stock Five Years Ago
Medtronic PulseSelect PFA System Demonstrates Impressive Results in Landmark PULSED AF Global IDE Trial
ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial
AF Global's Attributable Profit Plummets 91% in FY22
03:18 AM EST, 02/24/2023 (MT Newswires) -- AF Global's (SGX:L38) profit attributable to shareholders for 2022 dropped 91% year over year to SG$553,000 from SG$5.8 million. Earnings per share of the o
AF Global Narrows Loss, Revenue Soars 192% in H1
08:40 AM EDT, 08/05/2022 (MT Newswires) -- AF Global (SGX:L38), reported that revenue for the six months ending June 30, 2022 jumped 192% to SG$5.9 million ($4.3 million), up from SG$2.0 million in th
Singapore Stocks Close Marginally Higher; ESR-Logos REIT Shares Jump Over 1% on Divestment of Australian Property
05:32 AM EDT, 07/25/2022 (MT Newswires) -- Singapore's Straits Times Index opened some five points lower on Monday at 3,176.01, around which it hovered all day before crawling into positive territory
AF Global Anticipates Losses in January-June Period; Shares Plummet 10%
12:28 AM EDT, 07/25/2022 (MT Newswires) -- AF Global (SGX:L38) expects to post a loss in the six months ended June 30, due to the negative impact of the COVID-19 pandemic on the company's hospitality
AF Global Warns of Losses in 2021 Amid Negative Impact of COVID-19
02:07 AM EST, 01/31/2022 (MT Newswires) -- AF Global (SGX:L38) expects to record a loss for the 12 months ended Dec. 31, 2021, mainly due to the negative impact of the COVID-19 pandemic on the group'
AF Global's Attributable Loss Widens in H1 as Revenue Plummets 75%
12:43 AM EDT, 08/06/2021 (MT Newswires) -- AF Global's (SGX:L38) loss attributable to shareholders widened in the first half to SG$3.8 million ($2.8 million), or SG$0.0036 per share, from SG$1.1 mill
Analysis
Price Target
No Data
